Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StockTalk | Cannabis Report: Canadian retailer hits German medical market

Jonathon Brown Jonathon Brown, The Market Online
0 Comments| January 17, 2025

{{labelSign}}  Favorites
{{errorMessage}}

Canada’s largest cannabis retailer will take its talents into the German medical cannabis market by acquiring 51 per cent of pharmaceutical wholesaler Purecan GmbH for $7.1 million. Consideration represents an enterprise valuation of $14 million. Purecan will soon launch a telemedicine portal for German medical cannabis patients.

Click to enlarge
(Source: Adobe Stock)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Aurora announces German internship program

2 | Tilray’s gross profit increased by 29 per cent year-over-year, reaching $61 million in Q2

3 | MediPharm offers update on Napanee facility sale to Kensana Health

4 | Glow Lifetech makes Atlantic Canada debut with MOD drops

Click to enlarge

Top Cannabis Stocks Jan. 10 to Jan. 16, 2025

1. T.TLRY | 14,594 views | Tilray Brands Inc.
2. T.WEED | 6,118 views | Canopy Growth Corp.
3.C.CURA | 3,874 views | Curaleaf Holdings Inc.
4. T.LABS | 3,566 views | Medipharm Labs Corp.
5. C.OILS | 1,105 views | Nextleaf Solutions Inc.
6. C.TGIF | 705 views | 1933 Industries Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.




{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company